Phoenix Biotech Acquisition logo
Phoenix Biotech Acquisition
PBAX | NASDAQ
Chart Builder DCF Calculator
$5.85
+$0.37 (+6.75%)
At close: Feb 14, 2024, 03:56 PM ET

Phoenix Biotech Acquisition Company Profile

Company profile explained

Company Profile

Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.

Key Executives

Name Position
Christopher Ehrlich Chief Executive Officer & Director
Daniel E. Geffken Chief Financial Officer
Douglas Carl Fisher President

Latest SEC Filings

Date Type Title
Aug 31, 2026 8-K Current Report
Aug 14, 2026 424B3 Filing
Aug 14, 2026 10-Q Quarterly Report
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 17, 2026 424B3 Filing
Jul 17, 2026 8-K Current Report
Jul 13, 2026 25-NSE Filing
Jun 26, 2026 424B3 Filing
Jun 26, 2026 8-K Current Report
May 29, 2026 424B3 Filing
View All SEC Filings ➞
Phoenix Biotech Acquisition
Phoenix Biotech Acquisition logo
Country United States
IPO Date Nov 30, 2021
Industry Shell Companies
Sector Financial Services
Employees n/a
CEO Christopher B. Ehrlich

Contact Details

2201 Broadway Oakland, California 94612 United States
n/a

Stock Details

Ticker Symbol PBAX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001870404
CUSIP Number 71902K105
ISIN Number US71902K1051
SIC Code 6770

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.